Truist raised the firm’s price target on Medtronic (MDT) to $93 from $89 and keeps a Hold rating on the shares after its Q3 earnings beat. Despite the organic revenue miss, Medtronic saw ...

Goldman Sachs analyst David Roman raised the firm’s price target on Medtronic (MDT) to $85 from $83 and keeps a Sell rating on the shares. The ...

February 18, 2025Medtronic plc beats earnings expectations. Reported EPS is $1.39, expectations were $1.36. Ryan Weispfenning ...

Medtronic PLC (MDT) reports robust revenue and EPS growth, driven by innovations in Cardiac Ablation and Leadless Pacing, ...

Medtronic stock was down stock was down today after its third-quarter revenue slightly missed the Wall Street analyst consensus.

Medtronic's stock has been static, not delivering any gains for investors. Click here to find out why MDT stock is a Buy.

CEO Geoff Martha said Medtronic would submit its application for urological procedures to the Food and Drug Administration by ...

Shares of Medtronic ( MDT -6.63%) were sinking 7.3% as of 11:21 a.m. ET on Tuesday. The decline came after the medical device ...

I'm Ryan Weispfenning, vice president and head of Medtronic investor relations, and I appreciate that you're joining us for our fiscal '25 third-quarter video earnings webcast. Before we go inside to ...

Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by ...

Medtronic saw $8.3 billion in revenue during the third quarter of fiscal year 2025, according to financial results posted Feb. 18.

Medtronic reported Q3 revenue of $8.29 billion, missing estimates, while EPS of $1.39 topped forecasts. The company reaffirmed its FY25 organic growth guidance.